The Journal of Immunology, Vol 156, Issue 11 4415-4421, Copyright © 1996 by American Association of Immunologists

ARTICLES

Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement

MK Liszewski and JP Atkinson
Division of Rheumatology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Membrane cofactor protein (MCP; CD46) is a widely distributed C3b/C4b- binding glycoprotein that inhibits complement activation on host cells. MCP is expressed primarily as four isoforms that arise by alternative splicing of a single gene. The differences reside in the domains for O- glycosylation and cytoplasmic tails. Tissue-specific expression of isoforms and the differential processing of precursors mediated by the cytoplasmic tails suggest that isoform variations are biologically significant. The goal of these experiments was to characterize the complement inhibitory profile of the four commonly expressed isoforms. The MCP isoforms (BC) with a larger O-glycosylation domain bound C4b more efficiently than the C isoforms, which are smaller and less glycosylated in this region. Additionally, cytoprotection assays of individual clones of transfected isoforms bearing equivalent copy numbers demonstrated that the BC isoforms also provided enhanced protection in a classical pathway-mediated system and cleaved cell- bound C4b more efficiently than the C isoforms. Taken together, these data demonstrate that BC isoforms preferentially protect against the classical pathway of complement. Such findings indicate a physiologic role for isoform variation and have therapeutic implications for use of MCP isoforms as complement inhibitors in such areas as xenotransplantation.

This article has been cited by other articles:

				E. C. Nilsson, F. Jamshidi, S. M. C. Johansson, M. S. Oberste, and N. Arnberg Sialic Acid Is a Cellular Receptor for Coxsackievirus A24 Variant, an Emerging Virus with Pandemic Potential J. Virol., March 15, 2008; 82(6): 3061 - 3068. [Abstract] [Full Text] [PDF]

				C. J. Fang, V. Fremeaux-Bacchi, M. K. Liszewski, G. Pianetti, M. Noris, T. H. J. Goodship, and J. P. Atkinson Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome Blood, January 15, 2008; 111(2): 624 - 632. [Abstract] [Full Text] [PDF]

				M. Takemoto, K. Yamanishi, and Y. Mori Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells J. Gen. Virol., May 1, 2007; 88(5): 1415 - 1422. [Abstract] [Full Text] [PDF]

				K. M. Chung, M. K. Liszewski, G. Nybakken, A. E. Davis, R. R. Townsend, D. H. Fremont, J. P. Atkinson, and M. S. Diamond From the Cover: West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H PNAS, December 12, 2006; 103(50): 19111 - 19116. [Abstract] [Full Text] [PDF]

				M. Marttila, D. Persson, D. Gustafsson, M. K. Liszewski, J. P. Atkinson, G. Wadell, and N. Arnberg CD46 Is a Cellular Receptor for All Species B Adenoviruses except Types 3 and 7 J. Virol., November 15, 2005; 79(22): 14429 - 14436. [Abstract] [Full Text] [PDF]

				A. Gaggar, D. M. Shayakhmetov, M. K. Liszewski, J. P. Atkinson, and A. Lieber Localization of Regions in CD46 That Interact with Adenovirus J. Virol., June 15, 2005; 79(12): 7503 - 7513. [Abstract] [Full Text] [PDF]

				J. Esparza-Gordillo, E. G. d. Jorge, A. Buil, L. C. Berges, M. Lopez-Trascasa, P. Sanchez-Corral, and S. R. d. Cordoba Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32 Hum. Mol. Genet., March 1, 2005; 14(5): 703 - 712. [Abstract] [Full Text] [PDF]

				E. Wu, S. A. Trauger, L. Pache, T.-M. Mullen, D. J. Von Seggern, G. Siuzdak, and G. R. Nemerow Membrane Cofactor Protein Is a Receptor for Adenoviruses Associated with Epidemic Keratoconjunctivitis J. Virol., April 15, 2004; 78(8): 3897 - 3905. [Abstract] [Full Text] [PDF]

				D. B. Gill, M. Koomey, J. G. Cannon, and J. P. Atkinson Down-regulation of CD46 by Piliated Neisseria gonorrhoeae J. Exp. Med., November 3, 2003; 198(9): 1313 - 1322. [Abstract] [Full Text] [PDF]

				L. Johansson, A. Rytkonen, P. Bergman, B. Albiger, H. Kallstrom, T. Hokfelt, B. Agerberth, R. Cattaneo, and A.-B. Jonsson CD46 in Meningococcal Disease Science, July 18, 2003; 301(5631): 373 - 375. [Abstract] [Full Text] [PDF]

				R. J. Hasan, E. Pawelczyk, P. T. Urvil, M. S. Venkatarajan, P. Goluszko, J. Kur, R. Selvarangan, S. Nowicki, W. A. Braun, and B. J. Nowicki Structure-Function Analysis of Decay-Accelerating Factor: Identification of Residues Important for Binding of the Escherichia coli Dr Adhesin and Complement Regulation Infect. Immun., August 1, 2002; 70(8): 4485 - 4493. [Abstract] [Full Text] [PDF]

				M. L. Barilla-LaBarca, M. K. Liszewski, J. D. Lambris, D. Hourcade, and J. P. Atkinson Role of Membrane Cofactor Protein (CD46) in Regulation of C4b and C3b Deposited on Cells J. Immunol., June 15, 2002; 168(12): 6298 - 6304. [Abstract] [Full Text] [PDF]

				K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Complement Components, but Not Complement Inhibitors, Are Upregulated in Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1214 - 1219. [Abstract] [Full Text] [PDF]

				W. G. Brodbeck, C. Mold, J. P. Atkinson, and M. E. Medof Cooperation Between Decay-Accelerating Factor and Membrane Cofactor Protein in Protecting Cells from Autologous Complement Attack J. Immunol., October 1, 2000; 165(7): 3999 - 4006. [Abstract] [Full Text] [PDF]

				G. Wang, M. K. Liszewski, A. C. Chan, and J. P. Atkinson Membrane Cofactor Protein (MCP; CD46): Isoform-Specific Tyrosine Phosphorylation J. Immunol., February 15, 2000; 164(4): 1839 - 1846. [Abstract] [Full Text] [PDF]

				M. K. Liszewski, M. K. Leung, and J. P. Atkinson Membrane Cofactor Protein: Importance of N- and O-Glycosylation for Complement Regulatory Function J. Immunol., October 1, 1998; 161(7): 3711 - 3718. [Abstract] [Full Text] [PDF]

				G. Wang, M. Nonaka, C. He, N. Okada, I. Nakashima, and H. Okada Functional Differences Among Multiple Isoforms of Guinea Pig Decay-Accelerating Factor J. Immunol., March 15, 1998; 160(6): 3014 - 3022. [Abstract] [Full Text] [PDF]

				S. C. Makrides Therapeutic Inhibition of the Complement System Pharmacol. Rev., March 1, 1998; 50(1): 59 - 88. [Abstract] [Full Text] [PDF]

				M. K. Liszewski, M. Leung, W. Cui, V. B. Subramanian, J. Parkinson, P. N. Barlow, M. Manchester, and J. P. Atkinson Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46) J. Biol. Chem., November 22, 2000; 275(48): 37692 - 37701. [Abstract] [Full Text] [PDF]